Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-16

Clinical Trial Update: Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating add-on Enstilar in patients using Otezla for psoriasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enstilar (calcipotriene; betamethasone dipropionate)
  • OTEZLA (apremilast)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2024-04-16